170708-34-6

Basic information

• Product Name: Carbamic acid, 3-cyclopenten-1-yl-, phenylmethyl ester
• Synonyms: Carbamic acid, 3-cyclopenten-1-yl-, phenylmethyl ester
• CAS NO: 170708-34-6
• Molecular Formula: C13H15NO2
• Molecular Weight: 217.268
• Mol File: 170708-34-6.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: Carbamic acid, 3-cyclopenten-1-yl-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, 3-cyclopenten-1-yl-, phenylmethyl ester(170708-34-6)
• EPA Substance Registry System: Carbamic acid, 3-cyclopenten-1-yl-, phenylmethyl ester(170708-34-6)

Safety Data

• Hazardous Substances Data: 170708-34-6(Hazardous Substances Data)

Upstream product

• 7686-77-3 3-cyclopentene-1-carboxylic acid 
• 501-53-1 benzyl chloroformate 
• 91469-55-5 cyclopent-3-en-1-amine hydrogen chloride 
• 219844-47-0 N-(t-butyloxycarbonyl)-N-(methanesulfonyloxy)cyclopent-3-enylcarboxamide 
• 100-51-6 benzyl alcohol 
• 253680-54-5 methanesulfonic acid cyclopent-3-enyl ester 
• 14320-38-8 cyclopent-3-enol 

Downstream Products

• 1355328-26-5 benzyl bicyclo[3.1.0]hexan-3-ylcarbamate 

Relevant articles and documents

JAK KINASE INHIBITOR, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF IN FIELD OF MEDICINE

-

Functionalized Dialdehydes as Promising Scaffolds for Access to Heterocycles and β-Amino Acids: Synthesis of Fluorinated Piperidine and Azepane Derivatives

Functionalized dialdehydes are considered important substrates that can be transformed into various substituted heterocyclic, alicyclic, and polysubstituted compounds. Here, we report a robust stereocontrolled procedure for the synthesis of novel functionalized trifluoromethyl-containing piperidine and azepane derivatives, based on oxidative ring cleavage of the C=C bond of diversely substituted cycloalkenes, followed by reductive ring closure of the diformyl intermediates in the presence of fluorine-containing amines.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.